Cocrystal Pharma Shares Are Trading Higher. The Stock May Be Moving on Continued Strength Following a Q3 Earnings Beat Reported on Wednesday.

BenzingaNov 15 04:19

Noble Financial Maintains Cocrystal Pharma(COCP.US) With Buy Rating, Maintains Target Price $10

Futu NewsNov 14 21:31 · Ratings

Cocrystal Pharma (COCP) Receives a Buy From Noble Financial

TipRanksNov 14 21:15 · Ratings

Cocrystal Pharma | 8-K: Cocrystal Pharma Reports Third Quarter 2024 Financial Results and Provides Updates on its Antiviral Drug-Development Programs

SECNov 14 04:33

Cocrystal Pharma | 10-Q: Q3 2024 Earnings Report

SECNov 13 21:32 · Announcements

Cocrystal Pharma GAAP EPS of -$0.49 Beats by $0.08

Seeking AlphaNov 13 21:13